Human umbilical cord mesenchymal stem cell culture method

A technology of mesenchymal stem cells and culture methods, applied in the field of cell culture and human umbilical cord mesenchymal stem cells, can solve the problem of increasing microbial contamination such as viruses, fungi and mycoplasma, reducing the repeatability of cell culture, and the variability of serum cannot be ruled out Substance and other issues, to achieve the effect of improving repeatability, shortening culture time, and using safely

Inactive Publication Date: 2017-09-22
北京焕生汇生物技术研究院有限公司
View PDF5 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Both the enzymatic hydrolysis method and the tissue block culture method introduce components derived from animals. Since the components such as enzymes and serum derived from animals are not clear, the risk of microbial contamination such as viruses, fungi, and mycoplasma is increased. Serum cannot be excluded for at least one year The volatile substances contained in the serum may change the normal state of cells in the body when used in serum, which poses a safety hazard to the human body
[0010] In addition, due to differences between animal-derived enzymes and serum batches, which will also reduce the reproducibility of cell culture, both enzymatic hydrolysis and tissue block culture methods have problems such as complicated culture operations and long culture times

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human umbilical cord mesenchymal stem cell culture method
  • Human umbilical cord mesenchymal stem cell culture method
  • Human umbilical cord mesenchymal stem cell culture method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0036] The present invention will be specifically introduced below in conjunction with the accompanying drawings and specific embodiments.

[0037] 1. Obtaining umbilical cord tissue

[0038] Take the umbilical cord tissue of healthy puerpera at 39 to 40 weeks of normal delivery or caesarean section, put the umbilical cord tissue into a T75 culture bottle pre-filled with 100ml of tissue protection solution under clean conditions in the operating room, seal it, and transport it at 2°C to 8°C to the lab.

[0039] The composition of the tissue protection solution is: 2500 IU of heparin, 16000 IU of gentamicin, and 100 ml of 0.9% normal saline.

[0040] 2. Separation of Wharton's jelly

[0041] Put the umbilical cord tissue in a 15cm petri dish under the environment of a class 100 ultra-clean bench, wash it 2 to 3 times with PBS, clean the blood on the surface of the tissue, then cut the umbilical cord into small pieces (3cm to 5cm), and remove the inner part of the umbilical co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a human umbilical cord mesenchymal stem cell culture method, which comprises: (1) obtaining an umbilical cord tissue; (2) separating Wharton's Jelly; (3) cutting the Wharton's Jelly into tissue blocks, inoculating the tissue blocks into a T75 culture bottle, adding an appropriate amount of a primary culture medium, placing into a CO2 incubator, carrying out standing culture for 3 days, supplementing 5 ml of the primary culture medium at the 4th day, changing the culture medium every 2-3 days from the 4th day, removing the tissue block when cells start to migrate from the majority of the tissue blocks, changing the culture medium, and carrying out passage amplification when the cell density achieves 80% and above; and (4) after the treatment, re-suspending with a passage culture medium. According to the present invention, the animal-derived additive is not used during the culture process, such that the safety is provided; and the operation is simple and convenient, and the culture time is short.

Description

technical field [0001] The invention relates to a method for culturing cells, in particular to a method for culturing human umbilical cord mesenchymal stem cells, and belongs to the technical field of cell culture. Background technique [0002] Mesenchymal Stem Cells (MSCs) are derived from mesoderm and ectoderm in the early stages of development and exist in connective tissues and organ tissues throughout the body. Adult stem cells with multilineage differentiation potential. [0003] MSCs can differentiate into various tissue cells such as fat, bone, cartilage, muscle, tendon, ligament, nerve, liver, heart muscle and endothelium under specific induction conditions in vivo or in vitro, and they are still multidirectional after continuous subculture and cryopreservation. Therefore, it can be used as an ideal seed cell for the repair of tissue and organ damage caused by aging and disease. [0004] MSCs can secrete and produce a variety of cytokines that promote growth and d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0775
CPCC12N5/0668C12N2501/91C12N2509/00
Inventor 姚玲玲孟得龙杨敏杨苗宋丹刘得娟
Owner 北京焕生汇生物技术研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products